Albert David Limited

NSE ALBERTDAVD.NS

Albert David Limited Free Cash Flow Yield on February 06, 2025: 5.33%

Albert David Limited Free Cash Flow Yield is 5.33% on February 06, 2025, a 704.98% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Albert David Limited 52-week high Free Cash Flow Yield is 5.68% on June 04, 2024, which is 6.55% above the current Free Cash Flow Yield.
  • Albert David Limited 52-week low Free Cash Flow Yield is 0.66% on February 07, 2024, which is -87.67% below the current Free Cash Flow Yield.
  • Albert David Limited average Free Cash Flow Yield for the last 52 weeks is 4.18%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
NSE: ALBERTDAVD.NS

Albert David Limited

CEO Mr. Umesh Manohar Kunte
IPO Date June 14, 2016
Location India
Headquarters Gillander House
Employees 1,497
Sector Consumers Staples
Industries
Description

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.

Similar companies

ALEMBICLTD.NS

Alembic Limited

USD 1.33

2.50%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.88

1.88%

AMRUTANJAN.NS

Amrutanjan Health Care Limited

USD 7.69

0.17%

LINCOLN.NS

Lincoln Pharmaceuticals Limited

USD 8.70

8.00%

HESTERBIO.NS

Hester Biosciences Limited

USD 21.80

0.20%

StockViz Staff

February 8, 2025

Any question? Send us an email